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Study Objectives: There is limited information regarding 
sleep duration and determinants in Switzerland. We aimed to 
assess the trends and determinants of time in bed as a proxy 
for sleep duration in the Swiss canton of Geneva.
Methods: Data from repeated, independent cross-sectional 
representative samples of adults (≥ 18 years) of the Geneva 
population were collected between 2005 and 2011. Self-
reported time in bed, education, monthly income, and 
nationality were assessed by questionnaire.
Results: Data from 3,853 participants (50% women, 51.7 
± 10.9 years) were analyzed. No signifi cant trend was 
observed between 2005 and 2011 regarding time in bed 
or the prevalence of short (≤ 6 h/day) and long (> 9 h/day) 
time in bed. Elderly participants reported a longer time in bed 
(year-adjusted mean ± standard error: 7.67 ± 0.02, 7.82 ± 
0.03, and 8.41 ± 0.04 h/day for 35-50, 50-65, and 65+ years, 
respectively, p < 0.001), while shorter time in bed was reported 
by non-Swiss participants (7.77 ± 0.03 vs. 7.92 ± 0.03 h/
day for Swiss nationals, p < 0.001), participants with higher 
education (7.92 ± 0.02 for non-university vs. 7.74 ± 0.03 h/day 
for university, p < 0.001) or higher income (8.10 ± 0.04, 7.84 
± 0.03, and 7.70 ± 0.03 h/day for < 5,000 SFr; 5,000-9,500 
SFr, and > 9,500 SFr, respectively, p < 0.001). Multivariable-
adjusted polytomous logistic regression showed short and 
long time in bed to be positively associated with obesity and 
negatively associated with income.
Conclusion: In a Swiss adult population, sleep duration as 
assessed by time in bed did not change signifi cantly between 
2005 and 2011. Both clinical and socioeconomic factors 
infl uence time in bed.
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Short sleep duration has been associated with obesity, car-diovascular disease, and overall mortality.1-3 A decrease 
in sleep duration in the general population has been reported 
in some studies but not in others.4,5 A common assertion is 
that there is a trend toward fewer hours of sleep in most in-
dustrialized countries.6,7 Still, a recent review showed that 
self-reported sleep duration increased in seven countries and 
decreased in six others, and that the absolute changes were 
very small: increases ranged from 0.1 to 1.7 min per night each 
year, while decreases ranged from 0.1 to 0.6 min per night each 
year.8 Another study conducted in adults from 10 industrialized 
countries showed an increase in the percentage of long (> 9 
h/day) but not of short (≤ 6 h/day) sleepers.9 For instance, in 
the USA, the percentage of short sleepers fell from 11.7% in 
1985 to 9.2% in 2007, while the corresponding values for long 
sleepers were 26.3% and 37.5%; in the Netherlands, the per-
centage of short sleepers increased from 0.4% in 1975 to 0.8% 
in 2005, while the corresponding values for long sleepers were 
22.2% and 25.7%.9
Many socioeconomic factors such as low income, low ed-
ucational level, or belonging to a minority ethnic group are 
positively associated with short sleep.10,11 A study conducted 
Trends and Determinants of Time in Bed in Geneva, 
Switzerland
Cédric Gubelmann1; Idris Guessous, M.D.1,2; Jean-Marc Theler, M.D.2; José Haba-Rubio, M.D.3; Jean-Michel Gaspoz, M.D.2; 
Pedro Marques-Vidal, M.D., Ph.D.1,4
1Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland; 2Unit of Population 
Epidemiology, Division of Primary Care Medicine, Department of Community Medicine and Primary Care and Emergency 
Medicine, Geneva University Hospitals, Geneva, Switzerland; 3Center for Investigation and Research in Sleep, Lausanne University 
Hospital, Lausanne, Switzerland, and 4Department of Internal Medicine, Internal Medicine, Lausanne University Hospital, 
Lausanne, Switzerland
in the USA showed over one hour difference in sleep duration 
between whites and African/Caribbean immigrants.12 Similarly, 
low household income people present more insomnia-related 
symptoms than others.13 Switzerland is a European country 
characterized with a high socioeconomic status,14 but little is 
known regarding how sleep has evolved and of its associations 
with socioeconomic status and obesity. Hence, we analyzed 
seven-year (2005-2011) trends in time in bed (as a proxy for 
sleep duration) and in the prevalence of short and long time 
in bed in a representative population sample. The clinical and 
socioeconomic determinants of time in bed were also assessed.
BRIEF SUMMARY
Current Knowledge/Study Rationale: There is confl icting data whether 
sleep duration has decreased in the general population. We aimed at 
assessing trends and socioeconomic determinants of time in bed (as a 
proxy for sleep duration) in a representative sample of an adult popula-
tion of a Swiss canton.
Study Impact: This study adds further weight to the proponents that 
time in bed did not decrease in the general population. It also adds new 
information regarding the importance of socioeconomic traits in time 
in bed.
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MATERIALS AND METHODS
Recruitment
The Bus Santé study is a cross-sectional, population-based 
study conducted in the Swiss Canton of Geneva. The study 
was approved by the Ethical Committee of the Canton of 
Geneva, and a complete description has been published else-
where.15 Each year, a representative sample of approximately 
1,000 adults (500 men and 500 women) living in the Canton 
of Geneva is drawn. The study is conducted in 3 locations (2 
in the Geneva University Hospitals and one medical mobile 
unit). Canton Geneva has a high frequency (41%) of non-Swiss 
nationals, and 40% of Swiss residents are from other cantons 
(www.ge.ch/statistique/domaines/apercu.asp?dom=01_02_1).
Data Collected
Self-reported sleep duration was collected by questionnaire, 
where the participants indicated the usual time they went to bed 
and the usual time of waking up. All questionnaires were checked 
by trained collaborators. Sleep duration was computed as the 
time spent in bed, a method also used in other studies.16-18 Indeed, 
time in bed is easier to report and has shown an adequate correla-
tion with sleep time calculated by actigraphy.19 Conversely, no 
information was available regarding time spent in bed without 
sleeping, and no data on depression, anxiety, or sleep complaints 
was collected. Time in bed was further classified as short (≤ 6 h/
day) or long (> 9 h/day).9,20 A second classification using differ-
ent thresholds for short (≤ 7 h/day) and long (> 10 h/day) time 
in bed was also applied. The number of participants with a very 
short time in bed (< 5 h) was only 26 for the entire study period, 
and 44 after including participants with < 4 h of bed time. Hence, 
no category of very short time in bed was created.
Socioeconomic status included education (university level 
yes/no) and income, classified into < 5,000 SFr, 5,000-9,500 
SFr, and > 9,500 SFr (to convert to US$, multiply by 1.137; to 
convert to European €, multiply by 0.8218). For comparison, a 
common definition of poverty in Switzerland corresponds to 
a monthly income < 2,243 CHF for a single adult or < 3,990 
CHF for a couple with 2 children.21 Demographic data in-
cluded Swiss nationality (yes/no). Smoking status was clas-
sified into never, former (irrespective of time since quitting), 
and current smokers. Body mass index (BMI) was calculated 
from measured weight and height. Hypertension was defined 
as systolic blood pressure ≥ 140 mm Hg and/or diastolic blood 
pressure ≥ 90 mm Hg and/or presence of antihypertensive drug 
treatment; dyslipidemia was defined as the presence of a hypo-
lipidemic drug treatment; diabetes was defined as fasting glu-
cose ≥ 7.0 mmol/L or non-fasting glucose ≥ 10 mmol/L and/or 
presence of an antidiabetic drug treatment. As participants were 
examined during the whole day, it was not possible to have 
them all in the fasting state.
Participants were excluded if they had missing data, if their 
self-reported time in bed was < 4 or > 12 h/day, or if their BMI 
was < 15 or > 49 kg/m2.
Statistical Analysis
Statistical analyses were conducted using Stata version 12.0 
for windows (Stata Corp, College Station, Texas, USA). De-
scriptive results were expressed as number of participants (per-
centage) or as average ± standard deviation. Bivariate analyses 
were performed using χ2 or Fisher exact test for qualitative vari-
ables and Student t-test, analysis of variance, or Kruskal-Wal-
lis test for quantitative variables. Trends were assessed using 
linear regression for quantitative data and logistic regression 
separately for short and long sleepers (vs. reference category) 
as reported previously.9 Determinants of short or long time in 
bed were assessed using polytomous logistic regression (mlogit 
command of Stata) using the “normal” group as reference; the 
results were expressed as relative risk ratios (RRR) and 95% 
confidence interval (CI). For quantitative data, multivariable 
analysis was performed using analysis of variance and the re-
sults were expressed as multivariable-adjusted mean ± standard 
error. Statistical significance was assessed for p < 0.05.
RESULTS
Characteristics of Included and Excluded Participants
Of the initial 4,195 participants, 295 (7.0%) were excluded 
because of missing data for income or educational level, 29 
(0.7%) because of self-reported time in bed < 4 or > 12 h/day, 
and 18 (0.4%) because of a BMI < 15 or > 49 kg/m2 (Figure 1). 
Compared to participants retained for analysis, excluded par-
ticipants were older, more frequently women, and had a lower 
educational level, while no differences were found regarding 
smoking status, nationality, or income (Table S1, supplemental 
material).
The clinical characteristics according to gender and survey 
year of the 3,853 participants retained for analysis are summa-
rized in Table 1. No change occurred during the study period 
regarding the distribution of gender, age group, smoking status, 
Initial sample size 4,195
262 no income data
33 no education data
1 BMI < 15 kg/m2
17 BMI > 49 kg/m2
Final sample size 3,853
18 time in bed < 4 h/day
11 time in bed >12 h/day
Figure 1—Exclusion procedure.
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nationality, income category, or BMI group, while the percent-
age of participants with a university level tended to increase.
Trends in Time in Bed
Trends in reported time in bed, short and long time in bed are 
reported in Table 2. No significant change in reported time in bed 
was observed. Similarly, no significant trend was found for the 
prevalence of short (≤ 6 h/day), or long (> 9 h/day, p = 0.25) time 
in bed. When the thresholds for short and long time in bed were 
increased to ≤ 7 and > 10 h/day, respectively, a significant de-
crease in the prevalence of short time in bed was found (Table 2).
Determinants of Time in Bed
The associations between time in bed or prevalence of short 
and long time in bed and the participants’ clinical and socioeco-
nomic characteristics are summarized in Table 3. After adjusting for 
survey year, women, elderly, never smokers, and Swiss nationals 
reported longer time in bed, while participants with university level 
or with high income reported shorter time in bed.
Women, elderly participants, and Swiss nationals had a 
higher prevalence of long time in bed and a lower prevalence of 
short time in bed. Obese participants had a higher prevalence of 
both short and long time in bed. Participants with a university 
degree or a high income had a lower prevalence of long time 
in bed. These findings were replicated when the thresholds to 
define short and long time in bed were increased or after mul-
tivariable adjustment (Table 4). Further analysis of all partici-
pants with available data did not change the results (Table S2, 
supplemental material).
DISCUSSION
To our knowledge, this is one of the few studies assess-
ing trends and determinants of time in bed in a representative 
Table 1—Characteristics of non–excluded participants according to survey year.
2005 2006 2007 2008 2009 2010 2011 p value
N 188.0 225.0 251.0 434.0 950.0 936.0 869.0
Women (%) 50.5 45.3 49.0 49.5 51.6 49.6 50.6 0.78
Age (years) 51.8 ± 11.3 51.1 ± 11.2 51.7 ± 11.1 51.5 ± 11.1 51.4 ± 10.8 52.2 ± 11.1 51.5 ± 10.8 0.68
Body mass index (kg/m2) 25.0 ± 4.2 25.1 ± 3.8 25.1 ± 4.3 24.9 ± 4.1 25.0 ± 4.0 25.5 ± 4.5 25.3 ± 4.3 0.15
Body mass index categories (%)
Normal 54.3 52.9 55.8 56.5 53.4 51.7 53.5
Overweight 36.2 37.3 34.3 31.3 36.2 33.6 32.9 0.15
Obese 9.6 9.8 10.0 12.2 10.4 14.7 13.6
University level (%) 38.8 35.6 45.4 43.1 40.8 43.8 47.0 < 0.05
Smoking status (%)
Never 45.2 41.8 48.6 44.9 44.3 47.2 45.8
Former 30.9 33.8 29.9 33.4 33.9 32.5 34.4 0.85
Current 23.9 24.4 21.5 21.7 21.8 20.3 19.8
Swiss (%) 53.7 56.9 50.6 55.1 51.3 50.8 49.5 0.49
Income category (%) §
< 5,000 SFr 24.5 23.6 15.9 20.1 21.2 22.4 19.7
5,000 – 9,500 SFr 46.3 41.3 41.4 42.9 39.8 41.0 39.4 0.12
> 9,500 SFr 29.3 35.1 42.6 37.1 39.1 36.5 41.0
Results are expressed as mean ± standard deviation or as percentage. Statistical analysis by ANOVA or χ2. § to convert to Euro, multiply by 0.8218; to convert 
to US$, multiply by 1.137.
Table 2—Trends in reported time in bed and in the prevalence of short and long time in bed for the Geneva canton, 2005-2011.
2005 2006 2007 2008 2009 2010 2011 p value
N 188 225 251 434 950 936 869
Reported time in bed (h/day) 7.7 ± 1.1 7.8 ± 1.1 7.8 ± 1.2 7.9 ± 1.1 7.9 ± 1.1 7.8 ± 1.1 7.8 ± 1.1 0.54
Time in bed – classification 1
Short (≤ 6 h/day) 16 (8.5) 21 (9.3) 16 (6.4) 29 (6.7) 51 (5.4) 71 (7.6) 64 (7.4) 0.69
Reference (> 6 and ≤ 9 h/day) 155 (82.5) 185 (82.2) 211 (84.0) 367 (84.5) 801 (84.3) 789 (84.3) 741 (85.3)
Long (> 9 h/day) 17 (9.0) 19 (8.5) 24 (9.6) 38 (8.8) 98 (10.3) 76 (8.1) 64 (7.4) 0.25
Time in bed – classification 2
Short (≤ 7 h/day) 70 (37.2) 64 (28.5) 75 (29.9) 115 (26.5) 243 (25.6) 252 (26.9) 235 (27.0) 0.03
Reference (> 7 and ≤ 10h/day) 116 (61.7) 158 (70.2) 171 (68.1) 311 (71.7) 692 (72.8) 672 (71.8) 623 (71.7)
Long (> 10 h/day) 2 (1.1) 3 (1.3) 5 (2.0) 8 (1.8) 15 (1.6) 12 (1.3) 11 (1.3) 0.65
Results are expressed as mean ± standard deviation or as number of participants and (percentage). Statistical analysis of trends using linear regression for 
reported time in bed. Trends in short and long time in bed were assessed separately using logistic regression and the same reference category.
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sample of the Swiss canton of Geneva. Our results indicate that 
time in bed did not change during the study period (2005-2011) 
and that several clinical and socioeconomic factors significantly 
influence time in bed. The results add to the current knowledge 
of the association between time in bed and socioeconomic and 
demographic factors.
Trends in Time in Bed
Neither total time in bed nor the proportion of participants 
reporting short and long time in bed changed during the period 
2005-2011. This finding is in agreement with some studies8,22 
but not with others.4,23 A Finnish study found 18 minutes’ de-
crease in self-reported sleep duration in a 33-year time interval, 
but the proportion of short sleep remained stable.4 It is pos-
sible that our study spanned too few years to observe significant 
changes; the ongoing data collection of the Bus Santé study 
will allow a better assessment within several years.
Determinants of Time in Bed
The effect of gender on sleep duration is still a matter of de-
bate.11,13,24 In this study, women reported longer time in bed, re-
ported less frequently a short time in bed, and more frequently a 
long time in bed than men. Our results thus suggest that women 
tend to report longer time in bed than men, although objectively 
measured sleep data are needed to confirm our findings.
Contrary to other studies,25,26 elderly participants reported 
longer time in bed; they also had a lower frequency of short 
time in bed and a higher frequency of long time in bed. A lower 
prevalence of insufficient sleep among elderly subjects had 
also been reported in the behavioral risk factor surveillance 
system.27 A possible explanation is that retired people stay lon-
ger in bed without sleeping, thus overestimating their true sleep 
time. Indeed, changes in quality, quantity, and architecture of 
the sleep appear during aging so that elderly are less able to 
initiate and maintain sleep.28
There is an ongoing debate on the association between obe-
sity and short or long sleep.29 Short sleep duration might be 
associated to endocrine and metabolic changes,30 which in turn 
favor the development of obesity. In this study, no association 
was found between obesity and reported time in bed. Con-
versely, obesity was positively associated with both short and 
long time in bed irrespective of the thresholds used. This U-
shaped association has been described previously for other car-
diovascular risk factors, such as hypertension, type 2 diabetes, 
Table 3—Reported time in bed and prevalence of short and long time in bed according to the characteristics of the participants, 
Geneva canton.
Time in bed Classification 1 (h/day) Classification 2 (h/day)
h/day p ≤ 6 > 6 and ≤ 9 > 9 p ≤ 7 > 7 and ≤ 10 > 10 p
Overall 7.84 ± 1.10 268 (6.9) 3,249 (84.3)336 (8.7) 1,054 (27.4)2,743 (71.2) 56 (1.5)
Gender
Men (n = 1,924) 7.68 ± 0.02 < 0.001 188 (9.8) 1,612 (83.8)124 (6.4) < 0.001 637 (33.1) 1,263 (65.6) 24 (1.3) < 0.001
Women (n = 1,929) 8.01 ± 0.02 80 (4.1) 1,637 (84.9)212 (11.0) 417 (21.6) 1,480 (76.7) 32 (1.7)
Age group
35 – 50 (n = 1,858) 7.67 ± 0.02 153 (8.2) 1,606 (86.5)99 (5.3) 569 (30.6) 1,277 (68.7) 12 (0.7)
50 – 65 (n = 1,390) 7.82 ± 0.03 < 0.001 101 (7.3) 1,167 (83.9)122 (8.8) < 0.001 402 (28.9) 965 (69.4) 23 (1.7) < 0.001
65+ (n = 605) 8.41 ± 0.04 14 (2.3) 476 (78.7) 115 (19.0) 83 (13.7) 501 (82.8) 21 (3.5)
Body mass index categories
Normal (n = 2,062) 7.84 ± 0.02 120 (5.8) 1,787 (86.7)155 (7.5) 528 (25.6) 1,512 (73.3) 22 (1.1)
Overweight (n = 1,318) 7.84 ± 0.03 0.69 105 (7.9) 1,087 (82.5)126 (9.6) < 0.001 376 (28.5) 924 (70.1) 18 (1.4) < 0.001
Obese (n = 473) 7.88 ± 0.05 43 (9.1) 375 (79.3) 55 (11.6) 150 (31.7) 307 (64.9) 16 (3.4)
Smoking status
Never (n = 1,757) 7.88 ± 0.03 109 (6.2) 1,497 (85.2)151 (8.6) 444 (25.3) 1,292 (73.5) 21 (1.2)
Former (n = 1,279) 7.87 ± 0.03 < 0.001 87 (6.8) 1,072 (83.8)120 (9.4) 0.13 346 (27.1) 907 (70.9) 26 (2.0) < 0.01
Current (n = 817) 7.72 ± 0.04 72 (8.8) 680 (83.2) 65 (8.0) 264 (32.3) 544 (66.6) 9 (1.1)
Educational level
Non-university (n = 2,193) 7.92 ± 0.02 < 0.001 145 (6.6) 1,811 (82.6) 237 (10.8) < 0.001 570 (26.0) 1,581 (72.1) 42 (1.9) < 0.005
University (n = 1,660) 7.74 ± 0.03 123 (7.4) 1,438 (86.6)99 (6.0) 484 (29.2) 1,162 (70.0) 14 (0.8)
Income category (SFr) §
< 5,000 (n = 808) 8.10 ± 0.04 59 (7.3) 619 (76.6) 130 (16.1) 196 (24.3) 586 (72.5) 26 (3.2)
5,000 – 9,500 (n = 1,574) 7.84 ± 0.03 < 0.001 115 (7.3) 1,330 (84.5)129 (8.2) < 0.001 421 (26.7) 1,133 (72.0) 20 (1.3) < 0.001
> 9,500 (n = 1,471) 7.70 ± 0.03 94 (6.4) 1,300 (88.4)77 (5.2) 437 (29.7) 1,024 (69.6) 10 (0.7)
Swiss national
No (n = 1,812) 7.77 ± 0.03 < 0.001 158 (8.7) 1,512 (83.5)142 (7.8) < 0.001 545 (30.1) 1,241 (68.5) 26 (1.4) < 0.001
Yes (n = 1,917) 7.92 ± 0.03 96 (5.0) 1,639 (85.5)182 (9.5) 466 (24.3) 1,423 (74.2) 28 (1.5)
§ to convert to Euro, multiply by 0.8218; to convert to US$, multiply by 1.137. Results are expressed as calendar year-adjusted mean ± standard error or as 
number (row percentage). Statistical analysis by analysis of variance or χ2.
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and also for cardiovascular disease and overall mortality.31-34 It 
is possible that these associations between obesity and sleep 
might be due to different mechanisms: longer sleep durations 
might be a marker of low physical activity (which is associated 
with obesity), while short sleep durations might influence obe-
sity via endocrine and metabolic changes.30 Overall, our results 
suggest a U-shaped association between obesity and time in 
bed.
Smoking status has been associated with both short11,24 and 
long24 sleep. In this study, current smokers reported shorter 
time in bed and had a higher likelihood of reporting short time 
in bed. Possible explanations are the impact of nicotine on sleep 
duration35 or that smoking is a surrogate marker of stress, which 
has also been associated with short sleep time.24
Low educational level has been associated with lower sleep 
duration13,36; another study found low educational level to be 
negatively associated with both short and long sleep.26 In this 
study, participants with a university degree had a lower likeli-
hood of reporting long time in bed, but this association was 
no longer significant when the threshold to define long time in 
bed was increased. Overall, our results suggest that educational 
level does not influence time in bed in the Geneva population.
Lower income has been associated with poor sleep quality37 
and a higher prevalence of sleep complaints.20 In this study, in-
come was negatively associated with reported time in bed in 
both bivariate and multivariable analyses. Interestingly, partici-
pants with an income > 9,500 SFr had lower prevalence of short 
and long time in bed, but no difference was found when the 
threshold to define short time in bed was set at ≤ 7 hours/day. 
Our results do not confirm previous findings from a Finnish 
study,13 where a lower income was associated with short sleep 
duration, but are in agreement with a Chinese study,26 where 
higher income was inversely associated with both short and 
long sleep duration. It is possible that participants with a higher 
income have longer working hours or adopt a lifestyle that 
leads to shorter time in bed.38 After further adjusting for cardio-
vascular risk factors, a similar trend between income and time 
in bed was observed, i.e., participants in the highest income 
group tended to report less time in bed, although some RRRs 
were no longer significant (Table S3, supplemental material). 
Still, these results should be considered with some caution 
due to possible health care renunciations in the lowest income 
group39,40 and to misclassification for some cardiovascular risk 
factors due to non-fasting status.
Table 4—Multivariable analysis of determinants of reported time in bed and prevalence of short and long time in bed, Geneva 
canton.
Time in bed Classification 1 (h/day) Classification 2 (h/day)
h/day p ≤ 6 h/day p * > 9 h/day p * ≤ 7 h/day p * > 10 h/day p *
Year 0.99 (0.91–1.07) 0.75 0.98 (0.91–1.05) 0.55 0.95 (0.90–0.99) < 0.05 0.96 (0.81–1.13) 0.64
Gender
Men 7.69 ± 0.03 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Women 8.00 ± 0.02 < 0.001 0.44 (0.33–0.58) < 0.001 1.74 (1.35–2.24) < 0.001 0.58 (0.50–0.68) < 0.001 1.15 (0.64–2.04) 0.64
Age group
35 – 50 7.71 ± 0.03 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
50 – 65 7.83 ± 0.03 < 0.001 0.95 (0.72–1.25) 0.70 1.53 (1.15–2.04) < 0.005 0.94 (0.80–1.11) 0.49 2.04 (0.99–4.19) 0.06
65+ 8.35 ± 0.05 0.30 (0.17–0.53) < 0.001 2.82 (2.06–3.87) < 0.001 0.38 (0.29–0.50) < 0.001 2.54 (1.17–5.50) < 0.05
p value for trend < 0.001 < 0.001 < 0.001 < 0.01
BMI categories
Normal 7.85 ± 0.02 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Overweight 7.86 ± 0.03 0.83 1.24 (0.92–1.67) 0.15 1.30 (0.99–1.70) 0.06 1.11 (0.94–1.32) 0.21 1.11 (0.57–2.17) 0.76
Obese 7.82 ± 0.05 1.60 (1.08–2.37) < 0.05 1.35 (0.95–1.92) 0.10 1.51 (1.19–1.91) 0.001 2.57 (1.28–5.16) < 0.01
p value for trend < 0.05 < 0.05 0.001 0.01
Smoking status
Never 7.89 ± 0.03 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Former 7.86 ± 0.03 0.02 1.14 (0.84–1.55) 0.42 1.10 (0.84–1.44) 0.48 1.11 (0.93–1.31) 0.26 1.69 (0.92–3.10) 0.09
Current 7.75 ± 0.04 1.40 (1.00–1.95) 0.05 0.98 (0.71–1.35) 0.89 1.34 (1.10–1.62) < 0.005 1.05 (0.46–2.35) 0.92
p value for trend < 0.05 0.96 < 0.005 0.52
Educational level
Non-university 7.88 ± 0.02 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
University 7.81 ± 0.03 0.07 1.20 (0.90–1.59) 0.21 0.75 (0.57–0.98) < 0.05 1.08 (0.92–1.27) 0.33 0.70 (0.36–1.36) 0.29
Income category (SFr.)
< 5,000 7.98 ± 0.04 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
5,000 – 9,500 7.84 ± 0.03 < 0.001 0.82 (0.58–1.16) 0.26 0.58 (0.44–0.77) < 0.001 0.99 (0.80–1.22) 0.92 0.54 (0.29–1.02) 0.06
> 9,500 7.78 ± 0.03 0.63 (0.43–0.93) < 0.05 0.46 (0.33–0.64) < 0.001 1.06 (0.85–1.32) 0.63 0.37 (0.16–0.86) < 0.05
p value for trend < 0.05 < 0.001 0.29 < 0.05
Swiss national
No 7.78 ± 0.03 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Yes 7.91 ± 0.02 < 0.001 0.62 (0.47–0.81) < 0.001 1.18 (0.93–1.51) 0.17 0.77 (0.66–0.90) 0.001 0.97 (0.55–1.68) 0.90
BMI, body mass index; SFr, Swiss Francs. Results are expressed as multivariate-adjusted relative risk ratio and (95% confidence interval) using the reference 
group (non-short, non-long time in bed). * Test for the individual relative risk. Statistical analysis of trends by polytomous logistic regression.
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There are few studies focusing on sleep duration or sleep 
quality among migrants.41 In this study, Swiss nationals reported 
longer time in bed than foreigners; Swiss nationals also had a 
lower likelihood of reporting short time in bed, irrespective of 
the threshold applied. These findings are in agreement with two 
studies conducted in the USA where minority ethnic groups 
(African Americans) had shorter sleep duration,10,12 although 
this statement has been questioned.20 Possible explanations in-
clude living in a noisy environment, shift work, or higher work 
demands.41 Still, as there was no information regarding the liv-
ing environment of the participants, further studies are needed 
to identify the factors associated with shorter reported time in 
bed among migrants in Switzerland.
In this study, most factors associated with short time in bed 
were non-modifiable. Still, participants reporting short time in 
bed with a high income could be sensitized to the fact that poor 
sleep is associated with annual productivity losses of almost 
2,000 US$,42 and that increasing sleep duration could actually 
lead to a further increase in their wealth.
Study Limitations
This study has several limitations. First, time in bed was 
self-reported, and a reporting bias cannot be excluded, such 
as participants with a higher income tending to report shorter 
periods in bed as a long time in bed might not be socially ac-
ceptable. It has also been shown that the correlation between 
objectively and subjectively measured sleep duration is rather 
weak,43 and direct data on sleep quantity and quality were not 
available. Second, time in bed (and not sleep duration) was 
used; still, time in bed seems to be an adequate proxy for sleep 
duration as reasonable correlation between sleep time calcu-
lated by actigraphy and reports for bedtimes and wake times 
has been shown.19 Other studies also assessed sleep duration 
using the same methodology16-18; this method might also be less 
prone to bias, as it does not require mental calculations (con-
trary to calculating sleep duration) and no normative values 
exist.44 Furthermore, as the evaluation method for time in bed 
was the same for all participants and did not change during the 
study period, it is unlikely that our results regarding the lack 
of trend or the determinants of time in bed are biased. Finally, 
no data were collected on sleepiness, insomnia, or obstructive 
sleep apnea, so it was not possible to assess their prevalence 
or to associate time in bed with other sleep related symptoms.
CONCLUSION
Between 2005 and 2011, no changes were found regarding 
time in bed (as a proxy for sleep duration) or the prevalence of 
short or long sleepers in the adult Geneva population. Several 
clinical (gender, age, body mass index), behavioral (smoking), 
and socioeconomic (income, migrant status) factors signifi-
cantly influence time in bed.
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Table S1—Characteristics of included and excluded 
participants.
 Included Excluded p value
N 3,853.0 342.0  
Women (%) 50.1 60.5  < 0.001
Age (years) 51.7 ± 10.9 54.2 ± 10.9  < 0.001
University level (%) 43.1 33.0 0.001
Smoking status (%)
Never 45.6 50.3
Former 33.2 29.8 0.24
Current 21.2 19.9
Swiss (%) 51.4 50.8 0.82
Income category (%)
< 5,000 SFr 21.0 25.0
5,000 – 9,500 SFr 40.9 31.2 0.22
> 9,500 SFr 38.2 43.8
Results are expressed as mean ± standard deviation or as percentage. 
Statistical analysis by t-test or χ2.
SUPPLEMENTAL MATERIAL
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Table S2—Multivariable analysis of determinants of reported time in bed and prevalence of short and long time in bed, Geneva 
canton, all participants with available data.
Time in bed Classification 1 (h/day) Classification 2 (h/day)
h/day p ≤ 6 h/day p * > 9 h/day p * ≤ 7 h/day p * > 10 h/day p *
Year 0.99 (0.91–1.07) 0.76 0.98 (0.92–1.05) 0.61 0.95 (0.90–0.99) 0.02 0.95 (0.82–1.11) 0.54
Gender
Men 7.68 ± 0.03 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Women 7.98 ± 0.03 < 0.001 0.46 (0.35–0.60) < 0.001 1.68 (1.31–2.16) < 0.001 0.58 (0.5–0.68) < 0.001 1.02 (0.61–1.72) 0.94
Age group
35 – 50 7.69 ± 0.03 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
50 – 65 7.82 ± 0.03 < 0.001 0.94 (0.72–1.23) 0.65 1.53 (1.16–2.03) 0.003 0.94 (0.80–1.11) 0.46 1.92 (1.01–3.64) 0.05
65+ 8.32 ± 0.05 0.37 (0.22–0.61) < 0.001 2.83 (2.07–3.85) < 0.001 0.40 (0.30–0.51) < 0.001 2.47 (1.23–4.94) 0.011
p value for trend 0.001  < 0.001  < 0.001 0.004
BMI categories
Normal 7.84 ± 0.03 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Overweight 7.84 ± 0.03 0.94 1.23 (0.93–1.64) 0.15 1.26 (0.96–1.64) 0.09 1.12 (0.94–1.32) 0.21 0.94 (0.51–1.74) 0.84
Obese 7.82 ± 0.06 1.55 (1.05–2.27) 0.03 1.35 (0.96–1.90) 0.09 1.49 (1.18–1.89) 0.001 2.22 (1.17–4.21) 0.02
p value for trend 0.02 0.04 0.002 0.03
Smoking status
Never 7.86 ± 0.03 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Former 7.87 ± 0.03 0.06 1.08 (0.80–1.46) 0.63 1.13 (0.87–1.47) 0.371 1.09 (0.92–1.29) 0.33 1.72 (0.97–3.06) 0.07
Current 7.74 ± 0.04 1.47 (1.07–2.02) 0.02 1.06 (0.78–1.46) 0.701 1.36 (1.12–1.65) 0.002 1.60 (0.81–3.16) 0.18
p value for trend 0.02 0.58 0.001 0.09
Educational level
Non-university 7.86 ± 0.03 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
University 7.81 ± 0.03 0.21 1.14 (0.86–1.50) 0.36 0.75 (0.58–0.98) 0.04 1.07 (0.91–1.26) 0.38 0.75 (0.42–1.37) 0.35
Income category (SFr.)
< 5,000 7.96 ± 0.05 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
5,000 – 9,500 7.83 ± 0.03 0.01 0.81 (0.58–1.13) 0.22 0.58 (0.44–0.77) < 0.001 0.98 (0.80–1.21) 0.86 0.56 (0.31–1.00) 0.05
> 9,500 7.78 ± 0.03 0.62 (0.43–0.90) 0.02 0.46 (0.33–0.64) < 0.001 1.04 (0.84–1.30) 0.71 0.41 (0.19–0.86) 0.02
p value for trend 0.02  < 0.001 0.36 0.02
Swiss national
No 7.78 ± 0.03 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Yes 7.89 ± 0.03 0.005 0.64 (0.49–0.83) 0.001 1.16 (0.92–1.47) 0.21 0.77 (0.67–0.90) 0.001 0.89 (0.54–1.49) 0.67
BMI, body mass index; SFr, Swiss Francs. Results are expressed as multivariable-adjusted relative risk ratio and (95% confidence interval) using the reference 
group (non-short, non-long time in bed). * Test for the individual relative risk. Statistical analysis of trends by polytomous logistic regression.
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Table S3—Multivariable analysis of determinants of prevalence of short and long time in bed, Geneva canton, adjusting for 
cardiovascular risk factors.
Classification 1 (h/day) Classification 2 (h/day)
 ≤ 6 h/day p *  > 9 h/day p *  ≤ 7 h/day p *  > 10 h/day p *
Year 0.95 (0.81–1.11) 0.49 1.05 (0.92–1.19) 0.46 0.90 (0.82–0.98) 0.02 0.98 (0.72–1.34) 0.92
Gender
Men 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Women 0.58 (0.32–1.05) 0.07 2.34 (1.49–3.68) < 0.001 0.52 (0.38–0.71) < 0.001 0.86 (0.30–2.50) 0.78
Age group
35 – 50 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
50 – 65 0.88 (0.49–1.57) 0.65 2.17 (1.10–4.29) 0.03 1.02 (0.73–1.44) 0.90 NA
65+ 0.47 (0.18–1.24) 0.13 3.33 (1.58–7.04) < 0.001 0.49 (0.30–0.81) 0.01 NA
p value for trend 0.13  < 0.001 0.03
BMI categories
Normal 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Overweight 1.14 (0.62–2.10) 0.68 1.82 (1.11–3.00) 0.02 1.07 (0.76–1.50) 0.68 1.82 (0.43–7.70) 0.42
Obese 2.03 (0.98–4.21) 0.06 1.33 (0.72–2.47) 0.36 1.60 (1.04–2.47) 0.03 3.67 (0.84–16.1) 0.08
p value for trend 0.09 0.20 0.054 0.06
Smoking status
Never 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Former 1.31 (0.70–2.48) 0.40 1.10 (0.69–1.75) 0.68 1.36 (0.98–1.91) 0.07 3.59 (0.95–13.6) 0.06
Current 2.45 (1.26–4.80) 0.01 0.91 (0.50–1.67) 0.77 1.77 (1.20–2.62) 0.00 4.30 (0.88–20.9) 0.07
p value for trend 0.008 0.90 0.003 0.051
Educational level
Non-university 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
University 1.27 (0.72–2.25) 0.41 0.83 (0.51–1.34) 0.44 1.00 (0.73–1.38) 0.98 0.52 (0.14–2.02) 0.35
Income category (SFr.)
< 5,000 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
5,000 – 9,500 0.68 (0.34–1.39) 0.29 0.56 (0.34–0.92) 0.02 1.17 (0.78–1.76) 0.45 0.87 (0.28–2.71) 0.81
> 9,500 0.90 (0.43–1.86) 0.77 0.55 (0.30–1.00) 0.05 1.48 (0.95–2.29) 0.08 0.45 (0.08–2.58) 0.37
p value for trend 0.96 0.04 0.03 0.49
Swiss national
No 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Yes 0.52 (0.30–0.90) 0.02 1.04 (0.68–1.58) 0.86 0.79 (0.59–1.05) 0.11 1.12 (0.40–3.15) 0.83
Hypertension
No 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Yes 1.18 (0.64–2.17) 0.59 1.19 (0.74–1.90) 0.48 0.83 (0.59–1.17) 0.29 3.85 (1.01–14.8) 0.05
Diabetes
No 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Yes 0.40 (0.11–1.42) 0.16 1.33 (0.70–2.51) 0.38 0.81 (0.46–1.43) 0.47 0.87 (0.22–3.44) 0.85
Hypolipidemic drug treat.
No 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Yes 0.72 (0.38–1.36) 0.31 1.40 (0.87–2.24) 0.16 0.88 (0.62–1.25) 0.49 0.49 (0.16–1.48) 0.21
BMI, body mass index; SFr, Swiss Francs. Results are expressed as multivariable-adjusted relative risk ratio and (95% confidence interval) using the 
reference group (non-short, non-long time in bed). * Test for the individual relative risk. Statistical analysis of trends by polytomous logistic regression.
